Company / Free Cash Flow
PLUS THERAPEUTICS, INC. Free Cash Flow History
FY2011-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$10.7M
FY2025
5-year range
-$21.1M / -$10.7M
FY2021-FY2025
Trend
+17.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow has increased for 4 consecutive years, from -$35M in FY2015 to -$11M in FY2025.
Based on SEC 10-K filings.
-$11M in FY2025.
Improved from -$20M to -$11M over the past 8 years.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, free cash flow increased 17.8% year-over-year.
- Lowest free cash flow in the period was in FY2013.
Company context
Key Data Points
- Altman Z-Score -2.46 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$10.7M | +17.8% |
| FY2024 | -$13.0M | - |
| FY2018 | - | - |
| FY2017 | -$19.6M | +7.0% |
| FY2016 | -$21.1M | +39.9% |
| FY2015 | -$35.1M | -5.0% |
| FY2014 | -$33.4M | +6.9% |
| FY2013 | -$35.9M | -48.4% |
| FY2012 | -$24.2M | -0.6% |
| FY2011 | -$24.0M | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026